Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Gene therapy play Orchard raises L21M

    Orchard Therapeutics (London, U.K.) raised L21 million ($30.7 million) in a series A round to develop ex vivo autologous hematopoietic stem cell gene therapies for primary immune deficiencies, metabolic diseases and …

    Published on 5/3/2016
  • FINANCIAL NEWS: Ideaya raises $46M series A

    Cancer company Ideaya Biosciences Inc. (South San Francisco, Calif.) raised $46 million in a series A round from 5AM Ventures, Canaan Partners, Celgene Corp. (NASDAQ:CELG), WuXi Healthcare Ventures, Novartis Institute …

    Published on 5/3/2016
  • FINANCIAL NEWS: MVM closes fourth fund at $233M

    MVM Life Science Partners closed its fourth fund, MVM IV, at $233 million. The firm said it will invest $15-$30 million per company in healthcare companies of all stages in the U.S. and Europe. MVM invests in …

    Published on 5/3/2016
  • FINANCIAL NEWS: Verdine joins WuXi venture arm

    WuXi Healthcare Ventures hired Gregory Verdine as a venture partner. Verdine, a chemistry professor at Harvard University, is the co-founder of numerous biotechs, including natural products company Warp Drive Bio LLC (…

    Published on 5/3/2016
  • FINANCIAL NEWS: 5AM incubator spinout Homology raises $43.5M

    Gene editing company Homology Medicines Inc. spun out of 5AM Ventures' incubator with a $43.5 million series A round led by 5AM and Arch Venture Partners. Temasek, Deerfield and Arch Overage Fund also participated. …

    Published on 5/2/2016
  • FINANCIAL NEWS: Ophthalmic play Graybug raises $44.5M

    Graybug Vision Inc. (Redwood City, Calif.) raised $44.5 million in a series B round led by new investor Deerfield. New investors OrbiMed Advisors and Clarus Ventures also participated, along with existing investor …

    Published on 5/2/2016
  • FINANCIAL NEWS: Former Kythera team raises $34M for Sienna

    Aesthetic dermatology play Sienna Biopharmaceuticals Inc. (Westlake Village, Calif.) raised $34 million in a series A round. The start-up's management team includes former executives from aesthetics company Kythera …

    Published on 4/29/2016
  • FINANCIAL NEWS: Theravance, Ignyta raise follow-ons

    Theravance Biopharma Inc. (NASDAQ:TBPH) and Ignyta Inc. (NASDAQ:RXDX) raised a combined $150 million in follow-ons. Theravance raised $100.1 million through the sale of 4.8 million shares at $21. The company proposed …

    Published on 4/29/2016
  • FINANCIAL NEWS: Gilead HCV sales short of expectations in 1Q16

    Gilead Sciences Inc. (NASDAQ:GILD) slipped $5.35 to $91.65 in early after-hours trading Thursday after it reported 1Q16 earnings that missed analysts' estimates, in part due to lower than expected revenue from HCV drug …

    Published on 4/28/2016
  • FINANCIAL NEWS: Samsung BioLogics sets sights on Korean IPO

    Contract manufacturer Samsung BioLogics (Seoul, South Korea) is planning to list shares in South Korea this year. The company plans to select lead managers next month before deciding on the number of shares and timing.…

    Published on 4/28/2016
  • FINANCIAL NEWS: UBS, MPM close $471M cancer fund

    UBS Group AG (NYSE:UBS) raised $471 million for the UBS Oncology Impact Fund, which will invest in early stage cancer treatments. MPM Capital is collaborating with UBS on the fund. UBS said it will invest a portion of …

    Published on 4/27/2016
  • FINANCIAL NEWS: Vertex sales jump but Orkambi misses estimates

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) reported 1Q16 revenues of $398.1 million, up from $138.5 million in 1Q15 but missing analysts' estimates of $439.4 million. The shortfall was attributable to cystic fibrosis …

    Published on 4/27/2016
  • FINANCIAL NEWS: Allied Minds creates funding vehicle for BMS JV

    The newly formed ABLS Capital subsidiary of Allied Minds plc (LSE:ALM) has secured commitments of up to $80 million to fund programs in Allied Minds' joint venture with Bristol-Myers Squibb Co. (NYSE:BMY). The funds …

    Published on 4/26/2016
  • FINANCIAL NEWS: Cancer play FLX raises $50M in series B

    FLX Bio Inc. (South San Francisco, Calif.) raised $50 million in a series B round with The Column Group, Topspin Partners, Kleiner Perkins Caufield & Byers and Celgene Corp. (NASDAQ:CELG). FLX's lead product, FLX925, is…

    Published on 4/26/2016
  • FINANCIAL NEWS: Weill's $185M gift creates UCSF neuroscience institute

    The University of California San Francisco said the Weill Family Foundation and Joan and Sanford Weill donated $185 million to establish the UCSF Weill Institute for Neurosciences. The university said the donation is …

    Published on 4/26/2016
  • FINANCIAL NEWS: Hua Medicine closes series C round

    Hua Medicine Ltd. (Shanghai, China) raised about $50 million in a series C round led by Chinese private equity firm Harvest Investments. Existing investors Frontline BioVentures, Arch Venture Partners, Venrock, Eight …

    Published on 4/22/2016
  • FINANCIAL NEWS: Microbiome plays Second Genome, Enterome raise funds

    Second Genome Inc. (South San Francisco, Calif.) and Enterome Bioscience S.A. (Paris, France) each raised venture rounds on Wednesday.Second Genome raised $42.6 million in a series B round co-led by new investors Pfizer…

    Published on 4/20/2016
  • FINANCIAL NEWS: DalCor raises $100M in series B

    DalCor Pharma U.K. Ltd. (London, U.K.) raised $100 million in a series B round with Sanderling Ventures, Andre Desmarais, Caisse de depot et placement du Quebec, the Fonds de solidarite FTQ, CTI Life Sciences and …

    Published on 4/19/2016
  • FINANCIAL NEWS: Illumina sinks after weakened 2016 forecast

    Illumina Inc. (NASDAQ:ILMN) lost $41.25 (23%) to $136.88 on Tuesday after it reported preliminary 1Q16 revenues that missed analyst expectations and said 2016 revenue growth will be slower than expected. It gave the new…

    Published on 4/19/2016
  • FINANCIAL NEWS: GeNeuro raises EUR 33 million in IPO

    GeNeuro S.A. (Euronext:GNRO) raised EUR 33 million ($37.3 million) through the sale of 2.5 million shares at EUR 13 in an IPO. Trading of its shares is expected to begin Tuesday on Euronext.GeNeuro's GNbAC1 is in Phase …

    Published on 4/18/2016
  • FINANCIAL NEWS: Financial tracks

    Investment fund Apollo Therapeutics named Richard Butt CEO, effective May 23. Butt was senior director and research project leader in the neuroscience and pain research unit of Pfizer Inc. (NYSE:PFE).

    Published on 4/15/2016
  • FINANCIAL NEWS: Organogenesis raises $30M round

    Wound care company Organogenesis Inc. (Canton, Mass.) said it raised about $30 million in a venture round from existing investors.Organogenesis markets Apligraf and Dermagraft to treat diabetic foot ulcers and other …

    Published on 4/15/2016
  • FINANCIAL NEWS: GenSight withdraws U.S. listing

    Gene therapy company GenSight Biologics S.A. (Paris, France) withdrew its proposed NASDAQ listing, citing market conditions.In July 2015, the company filed to raise up to $100 million through an offering of ADSs (see …

    Published on 4/14/2016
  • FINANCIAL NEWS: Imara raises $31M, licenses sickle cell therapies

    Sickle cell play Imara Inc. (Cambridge, Mass.) raised a tranched $31 million series A round led by New Enterprise Associates (NEA). Pfizer Venture Investments, Lundbeckfond Ventures, Bay City Capital and Alexandria …

    Published on 4/14/2016
  • FINANCIAL NEWS: Bavarian Nordic cancels U.S. offering, prices private placement

    Bavarian Nordic A/S (CSE:BAVA) said Wednesday it would withdraw its proposed NASDAQ listing, and instead announced the pricing of a DKK664.8 million ($101.6 million) private placement through the sale of 2.8 million …

    Published on 4/13/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993